{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 37,
        "end": 41
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 121,
        "end": 140
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "24733796_3",
  "text": "PATIENTS AND METHODS : Patients with HER2 -positive locally advanced breast cancer or MBC were treated with 3.6 mg/kg T- DM1 plus pertuzumab ( 840-mg loading dose , then 420 mg subsequently ) once every 3 weeks ."
}
